Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2017 Jun;25(6):1797-1807.
doi: 10.1007/s00520-017-3584-0. Epub 2017 Jan 20.

The relationship between patient activation, confidence to self-manage side effects, and adherence to oral oncolytics: a pilot study with Michigan oncology practices

Teresa M Salgado  1   2 , Emily Mackler  3 , Jane A Severson  2 , Jamie Lindsay  2 , Peter Batra  1 , Laura Petersen  2 , Karen B Farris  1   2
Affiliations
Multicenter Study

The relationship between patient activation, confidence to self-manage side effects, and adherence to oral oncolytics: a pilot study with Michigan oncology practices

Teresa M Salgado et al. Support Care Cancer. 2017 Jun.

Abstract

Purpose: The Michigan Oncology Quality Consortium (MOQC) is a continuous quality improvement collaborative seeking to improve oncology care in Michigan, including for patients taking oral chemotherapy. The aim of this study was to assess the relationship between patient activation, confidence to self-manage side effects, and adherence to oral oncolytics to inform future oncology care.

Methods: A multicenter cross-sectional observational study was conducted using an online survey to examine patient activation (patient activation measure, PAM), health literacy, symptom burden (Edmonton Symptom Assessment System, ESAS), confidence to self-manage side effects (fatigue, nausea, and diarrhea), and adherence to oral oncolytics. Inclusion criteria were patients taking an oral oncolytic for at least 1 month. Bivariate analyses and logistic regression were performed to evaluate relationships between the variables.

Results: A total of 125 respondents, mean (SD) age 66.2 (13.6), 57.7% female, and 95.1% Caucasian completed the survey. The mean (SD) PAM score was 65.0 (18.0). Confidence to manage fatigue, nausea, and diarrhea was associated with higher activation, and confidence to self-manage fatigue and diarrhea were associated with higher health literacy. About 30% of participants reported some level of non-adherence to oral oncolytics, and those who experienced side effects (Fisher's exact test p = 0.033) and with shorter length of therapy (t test p = 0.027) were significantly more likely to be non-adherent.

Conclusions: These findings show that there is room for improvement across practices involved with MOQC with regard to supporting patients taking oral oncolytics. Patients will need to improve their activation levels, and oncology clinics will need to create new workflows in order to enhance self-care management ability for patients taking oral oncolytics.

Keywords: Adherence; Oral chemotherapy; Quality improvement; Self-management.

PubMed Disclaimer

References

    1. AIDS Behav. 2008 Jan;12(1):86-94 - PubMed
    1. Eur J Cancer Care (Engl). 2014 Jan;23(1):22-35 - PubMed
    1. Res Social Adm Pharm. 2015 May-Jun;11(3):e133-43 - PubMed
    1. Psychooncology. 2012 Sep;21(9):977-85 - PubMed
    1. Cancer Epidemiol. 2014 Jun;38(3):214-26 - PubMed

Publication types

Substances

LinkOut - more resources